Flash chromatography (FC) was carried out using Merck silica
gel 60 (230–400 mesh). The ee was determined by HPLC using a
Chiralpak AS column with i-PrOH/hexane as eluent. All cata-
References
1
For catalytic asymmetric reactions in water see e.g.: Adv. Synth.
Catal., 2002, 344, pp. 219–451.
lytic reactions were carried out under an atmosphere of N or Ar.
2
2
For an overview on enzymatic transaminations see: (a)
Y. Murakami, J. Kikuchi, Y. Hisaeda and O. Hayashida, Chem. Rev.,
1996, 96, 721–758; (b) A. E. Braunstein, in The Enzymes, ed.
P. D. Boyer, Academic Press, New York, 1973, vol. 9; (c) see
e.g. Transaminases, eds. P. Christen and D. E. Metzler, John Wiley,
New York, 1985; (d ) Biochemistry of Vitamin B6 and PQQ, eds.
G. Marino, G. Sannia and F. Bossa, Birkhauser Verlag, Basel, 1994;
(e) A. E. Evangolopoulos, Chemical and Biological Aspects of
Materials
All commercially available compounds were used without any
further purification. 2,2Ј-Isopropylidenebis[(4R)-4-phenyl-2-
oxazoline], TMSCHN2 (2.0 M in hexane), 4-picolylamine,
pyridoxamine dihydrochloride hydrate, ethyl pyruvate, indole-
Vitamin B Catalysis, A. R. Liss, New York, 1984; ( f ) A. E. Martell,
3
-pyruvic acid, BEt , B(OH) , BCl , B(OPh) , Zn(OTf ) ,
6
3
3
3
3
2
Acc. Chem. Res., 1989, 22, 115–124.
See e.g. L. Streyer, in Biochemistry, W. E. Freeman and Company,
New York, 1999, p. 633.
Selected papers: (a) D. E. Metzler and E. E. Snell, J. Am. Chem.
Soc., 1952, 74, 979–983; (b) M. Ikawa and E. E. Snell, J. Am. Chem.
Soc., 1954, 76, 637; (c) D. E. Metzler, J. Olivard and E. E. Snell,
J. Am. Chem. Soc., 1954, 76, 644–648; (d ) D. E. Metzler, M. Ikawa
and E. E. Snell, J. Am. Chem. Soc., 1954, 76, 648–652; (e) M. Ikawa
and E. E. Snell, J. Am. Chem. Soc., 1954, 76, 653–655; ( f )
J. B. Longenecker and E. E. Snell, Proc. Natl. Acad. Sci. USA, 1956,
[
Cu()(CH CN) ]PF and the ligands 9f and 9g were purchased
3 4 6
3
4
from Aldrich. The indane-derived ligand and its Zn() complex
1
5
8
9
9
were synthesised according to a literature method. Ligand
c was purchased from Strem Chemicals, whereas the ligands
a, 9b, 9d and 9e were synthesised according to literature
16
17
18
5
methods. The P–N ligands and the corresponding Cu() com-
19
plexes were synthesised according to described methods.
General procedure for the catalytic (enantioselective)
transamination of ꢀ-keto esters
4
2, 221–227; (g) Y. Matsushima and A. M. Martell, J. Am. Chem.
Soc., 1967, 89, 1331–1335; (h) O. A. Gansow and R. H. Holm,
J. Am. Chem. Soc., 1968, 90, 5629–5631; (i) S. Matsumoto and
Y. Matsushima, J. Am. Chem. Soc., 1972, 94, 7211–7213; (j) L. Liu
and R. Brelow, J. Am. Chem. Soc., 2002, 124, 4978–4979;
(k) E. Fasella, S. D. Dong and R. Breslow, Bioorg. Med. Chem.,
1999, 7, 709–714.
The Lewis acid (0.1 mmol, 20 mol% versus the nitrogen source)
and the chiral ligand (0.11 mmol, 22 mol%) were stirred for
3
0 min under vacuum. Then 2 ml of solvent was added and
the solution was stirred for 1 h before the nitrogen source
0.5 mmol) and the α-keto ester (1 mmol, 2 eq.) were added.
5
6
(a) K. Bernauer, R. Deschenaux and T. Taura, Helv. Chim. Acta,
(
1
983, 66, 2049–2057; (b) R. Deschenaux and K. Bernauer, Helv.
The resulting mixture was stirred for 20 h and hydrolysed by the
addition of H O (2 eq.) and CF COOH (1 eq.). The free amino
Chim. Acta, 1984, 67, 373–377.
2
3
(a) Y. Tachibana, M. Ando and H. Kuzuhara, Chem. Lett., 1982,
1765–1768; (b) Y. Tachibana, M. Ando and H. Kuzuhara, Chem.
Lett., 1982, 1769–1772; (c) Y. Tachibana, M. Ando and
H. Kuzuhara, Bull. Chem. Soc. Jpn., 1983, 56, 2263–2266;
group was protected by adding NEt (210 µl, 3 eq.) and (Boc) O
3
2
(
5
218 mg, 2 eq.) to the MeOH solution and stirred for 30 min at
0 ЊC. After cooling the mixture to ambient temperature the
20
(
d ) Y. Tachibana, M. Ando and H. Kuzuhara, Bull. Chem. Soc. Jpn.,
solvent was removed and the oily residue was purified by FC
1
983, 56, 3652–3656; (e) S. C. Zimmermann and R. Breslow, J. Am.
using CH Cl /Et O 9 : 1 as eluent. The purity of the products
2
2
2
1
Chem. Soc., 1984, 106, 1490–1491.
was checked by H NMR and TOF MS and the values of the
7
L. Liu, M. Rozenman and R. Breslow, J. Am. Chem. Soc., 2002, 124,
21
22
21
known compounds 5a, 5e and 5h were compared with the
1
2660–12661.
products described in the literature.
8 L. Liu and R. Breslow, J. Am. Chem. Soc., 2003, 125, 12110–12111.
(a) A. Hjelmencrantz and U. Berg, J. Org. Chem., 2002, 67, 3585–
594; (b) V. A. Soloshonok, I. V. Soloshonok, V. P. Kukhar
9
3
Ethyl N-tert-butyloxycarbonyl-2-amino-4-methyl-pentanoate 5b
and V. K. Svedas, J. Org. Chem., 1998, 63, 1878–1884; (c)
V. A. Soloshonok and O. Taizo, J. Org. Chem., 1997, 62, 3030–3031;
(d ) D. A. Jaeger, M. D. Broadhurst and D. J. Cram, J. Am. Chem.
Soc., 1979, 101, 717–732; (e) M. D. Toney and J. F. Kirsch,
Biochemistry, 1993, 32, 1471–1479.
0 K. R. Knudsen, S. Bachmann and K. A. Jørgensen, Chem.
Commun., 2003, 2602–2603.
1
H NMR (CDCl ): δ 4.89 (br d, 1H, J = 8.4 Hz, NH ), 4.28 (m,
3
1
H, CH ), 4.18 (q, 1H, J = 6.8 and 14.0 Hz, OCH ), 1.69 (m, 1H,
2
CH ), 1.59 (m, 1H, CH ), 1.48 (m, 1H, CH(CH ) ), 1.44 (s, 9H,
2
2
3 2
C(CH ) ), 1.27 (t, 3H, J = 7.6 Hz, CH ), 0.94 (d, 3H, J = 3.2 Hz,
3
3
3
1
13
CH ), 0.93 (d, 3H; J = 3.2 Hz, CH ); C NMR (CDCl ):
3
3
3
δ 173.5, 155.4, 79.7, 61.1, 52.1, 41.9, 28.3, 24.8, 22.8, 21.9, 14.1;
1
1 M. P. Sibi and M. Liu, Curr. Org. Chem., 2001, 5, 719–755.
ϩ
ϩ
HRMS (ES TOF) calcd for C H NO [M ϩ Na] 282.1681,
12 G. S. M. Kiruba and M. W. Wong, J. Org. Chem., 2003, 68,
2874–2881.
13
25
4
found 282.1679.
1
3 The use of Cu(OTf )2 as catalyst for the half-transamination of
different α-keto esters 1 with pyridoxamine 2a or 4-picolylamine 2b
did not yield any transamination product. See also reference 10.
Ethyl N-tert-butyloxycarbonyl-2-amino-5-hexenoate 5c
1
H NMR (CDCl ): δ 5.77 (m, 1H, C(H )᎐CH ), 5.02 (m, 3H,
14 For P–N ligands in combination with Cu() see for instance: (a)
Y. C. Hu, X. M. Liang, J. W. Wang, Z. Zheng and X. Q. Hu, J. Org.
Chem., 2003, 68, 4542–4545; (b) L. Bernardi, A. S. Gothelf,
R. G. Hazell and K. A. Jørgensen, J. Org. Chem., 2003, 68, 2583–
2591; (c) X. M. Fang, M. Johannsen, S. L. Yao, N. Gathergood,
R. G. Hazell and K. A. Jørgensen, J. Org. Chem., 1999, 64,
4844–4849; (d ) J. Andrien, B. R. Steele, C. G. Screttas, C. J. Cardin
and J. Fornies, Organometallics, 1998, 17, 839–845.
3
᎐
2
CH᎐CH and NH ), 4.28 (dd, 1H, J = 8.0 and 13.2 Hz, CH ),
᎐
2
4
1
1
1
.18 (q, 2H, J = 6.8 and 14.4 Hz, OCH ), 2.12 (m, 2H, CH ),
2
2
.90 (m, 1H, CH ), 1.71 (m, 1H, CH ), 1.43 (s, 9H, C(CH ) ),
2
2
3 3
13
.27 (t, 3H, J = 7.2 Hz, CH ); C NMR (CDCl ): δ 172.8, 155.3,
37.0, 115.6, 79.8, 61.3, 53.0, 32.0, 29.4, 14.1; HRMS (ES TOF)
3
3
ϩ
ϩ
calcd for C H NO [M ϩ Na] 280.1525, found 280.1529.
13
23
4
1
5 D. M. Barnes, M. Ji, M. G. Fickes, M. A. Fitzgerald, S. A. King, H. E.
Morton, F. A. Plagge, M. Preskill, S. H. Wagaw, S. J. Wittenberger
and J. Zhiang, J. Am. Chem. Soc., 2002, 124, 13097–13105.
N-(tert-Butyloxycarbonyl)-2-(3-indolyl)glycin-methylester 5d
1
1
1
6 I. Alfonso, F. Rebolledo and V. Gotor, Tetrahedron: Asymmetry,
The ee was determined by HPLC on a Chiralpak AS column
1
999, 10, 367–374.
7 J. T. Seiders, W. D. Ward and R. H. Grubbs, Org. Lett., 2001, 3,
225–3228.
with hexane/i-PrOH 80:20 as eluent. R (min), 5.7 (d-isomer),
t
7
.3 (l-isomer). The absolute configuration was assigned
by comparison with a commercially available sample of
l )-tryptophan that has been derivatised to the Boc-protected
3
8 D. Seebach, A. K. Beck, R. Imwinkelried, S. Roggo and
(
A. Wonnacott, Helv. Chim. Acta, 1987, 70, 954–974.
19 See reference 14b and literature cited therein.
tryptophan methylester.
2
0 If the reaction was performed in MeNO , then the solvent had to be
2
removed under high vacuum before protecting the free amine,
otherwise a part decomposition of the desired product occurs.
1 O. Hayashida, L. Sebo and J. Rebek Jr., J. Org. Chem., 2002, 67,
Acknowledgements
2
This work has been made possible by a grant of the Danish
National Research Foundation.
8
291–8298.
22 B. Jiang and X.-H. Gu, Heterocycles, 2000, 53, 1559–1568.
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 2 0 4 4 – 2 0 4 9
2049